Editorial: Radioembolization for metastatic colorectal cancer: towards maturity, at last?
Authors : Hendlisz A, Sclafani F
Year : 2021
Journal : Curr Opin Oncol
Volume : 33
Pages : 351-352
Fortnightly or fractionated weekly docetaxel-cisplatin-5-FU as first-line treatment in advanced gastric and gastroesophageal junction adenocarcinoma: The randomized phase II DoGE study.
Authors : Deleporte A, Van den Eynde M, Forget F, Holbrechts S, Delaunoit T, Houbiers G, Kalantari HR, Laurent S, Vanderstraeten E, De Man M, Vergauwe P, Clausse M, Van Der Auwera J, DHondt L, Pierre P, Ghillemijn B, Covas A, Paesmans M, Ameye L, Awada A, Sclafani F, Hendlisz A
Year : 2021
Journal : Cancer Med
Volume : 10
Pages : 4366-4374
Rationale and design of REGINA, a phase II trial of neoadjuvant regorafenib, nivolumab, and short-course radiotherapy in stage II and III rectal cancer.
Authors : Bregni G, Vandeputte C, Pretta A, Senti C, Trevisi E, Acedo Reina E, Kehagias P, Liberale G, Moretti L, Bali MA, Demetter P, Flamen P, Carrasco J, DHondt L, Geboes K, Gokburun Y, Peeters M, Van den Eynde M, Van Laethem JL, Vergauwe P, Chapot CA, Buyse M, Deleporte A, Hendlisz A, Sclafani F
Year : 2021
Journal : Acta oncol (Stockholm)
Volume : 60
Pages : 549-553
Sex and Regorafenib Toxicity in Refractory Colorectal Cancer: Safety Analysis of the RegARd-C Trial.
Authors : Vandeputte C, Bregni G, Gkolfakis P, Guiot T, Pretta A, Kehagias P, Senti C, Reina EA, Van Bogaert C, Deleporte A, Geboes K, Delaunoit T, Demolin G, Peeters M, DHondt L, Janssens J, Carrasco J, Holbrechts S, Goeminne JC, Vergauwe P, Van Laethem JL, Flamen P, Hendlisz A, Sclafani F
Year : 2021
Journal : Clin Colorectal Cancer
Volume : 20
Pages : 326-333
Clinico-metabolic characterization improves the prognostic value of histological growth patterns in patients undergoing surgery for colorectal liver metastases.
Authors : Bohlok A, Duran Derijckere I, Azema H, Lucidi V, Vankerckhove S, Hendlisz A, Van Laethem JL, Vierasu I, Goldman S, Flamen P, Larsimont D, Demetter P, Dirix L, Vermeulen P, Donckier V
Year : 2021
Journal : J Surg Oncol
Volume : 123
Pages : 1773-1783
Anal squamous cell carcinoma: standards of care, new data and ongoing clinical trials.
Authors : Giunta EF, Bregni G, Hendlisz A, Sclafani F
Year : 2021
Journal : Curr Opin Oncol
Volume : 33
Pages : 372-377
Total neoadjuvant therapy for rectal cancer: Making sense of the results from the RAPIDO and PRODIGE 23 trials.
Authors : Giunta EF, Bregni G, Pretta A, Deleporte A, Liberale G, Bali MA, Moretti L, Troiani T, Ciardiello F, Hendlisz A, Sclafani F
Year : 2021
Journal : Cancer Treat Rev
Volume : 96
Pages : 102177
PD-1 and PD-L1 inhibitors in oesophago-gastric cancers.
Authors : Akin Telli T, Bregni G, Camera S, Deleporte A, Hendlisz A, Sclafani F
Year : 2020
Journal : Cancer Lett
Volume : 469
Pages : 142-150
Editorial: Adjuvant chemotherapy for gastrointestinal cancers: we can do much better.
Authors : Sclafani F, Hendlisz A
Year : 2020
Journal : Curr Opin Oncol
Volume : 32
Pages : 344-346
The lack of selection criteria for surgery in patients with non-colorectal non-neuroendocrine liver metastases.
Authors : Bohlok A, Lucidi V, Bouazza F, Daher A, Germanova D, Van Laethem JL, Hendlisz A, Donckier V
Year : 2020
Journal : World J Surg Oncol
Volume : 18
Pages : 106
Feasibility and clinical impact of routine molecular testing of gastrointestinal cancers at a tertiary centre with a multi-gene, tumor-agnostic, next generation sequencing panel.
Authors : Bregni G, Sticca T, Camera S, Akin Telli T, Craciun L, Trevisi E, Pretta A, Kehagias P, Leduc S, Senti C, Deleporte A, Vandeputte C, Saad ED, Kerger J, Gil T, Piccart-Gebhart M, Awada A, Demetter P, Larsimont D, Hendlisz A, Aftimos P, Sclafani F
Year : 2020
Journal : Acta oncol (Stockholm)
Volume : 59
Pages : 1438-1446
Treatment compliance in early-stage anal cancer.
Authors : Pretta A, Trevisi E, Bregni G, Deleporte A, Hendlisz A, Sclafani F
Year : 2020
Journal : Ann Oncol
Volume : 31
Pages : 1282-1284
Infiltrative tumour growth pattern correlates with poor outcome in oesophageal cancer.
Authors : Anciaux M, Demetter P, de Wind R, Gomez Galdon M, Vande Velde S, Lens G, Craciun L, Deleruelle A, Larsimont D, Lenaerts T, Sclafani F, Deleporte A, Donckier V, Hendlisz A, Vandeputte C
Year : 2020
Journal : BMJ Open Gastroenterol
Volume : 7
Novel strategies using modern radiotherapy to improve pancreatic cancer outcomes: toward a new standard?
Authors : Bouchart C, Navez J, Closset J, Hendlisz A, Van Gestel D, Moretti L, Van Laethem JL
Year : 2020
Journal : Ther Adv Med Oncol
Volume : 12
Pages : 1758835920936093
MOMENTUM: A Phase I Trial Investigating 2 Schedules of Capecitabine With Aflibercept in Patients With Gastrointestinal and Breast Cancer.
Authors : Camera S, Deleporte A, Bregni G, Trevisi E, Pretta A, Telli TA, Polastro L, Gombos A, Kayumba A, Ameye L, Piccart-Gebhart M, Awada A, Sclafani F, Hendlisz A
Year : 2020
Journal : Clin Colorectal Cancer
Volume : 19
Pages : 311-318.e1
Prognostic value of a three-scale grading system based on combining molecular imaging with <sup>68</sup>Ga-DOTATATE and <sup>18</sup>F-FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasias.
Authors : Karfis I, Marin G, Levillain H, Drisis S, Muteganya R, Critchi G, Taraji-Schiltz L, Guix CA, Shaza L, Elbachiri M, Mans L, Machiels G, Hendlisz A, Flamen P
Year : 2020
Journal : Oncotarget
Volume : 11
Pages : 589-599
Adjuvant chemotherapy for rectal cancer: Current evidence and recommendations for clinical practice.
Authors : Bregni G, Akin Telli T, Camera S, Deleporte A, Moretti L, Bali MA, Liberale G, Holbrechts S, Hendlisz A, Sclafani F
Year : 2020
Journal : Cancer Treat Rev
Volume : 83
Pages : 101948
Grey areas and evidence gaps in the management of rectal cancer as revealed by comparing recommendations from clinical guidelines.
Authors : Bregni G, Akin Telli T, Camera S, Baratelli C, Shaza L, Deleporte A, Moretti L, Bali MA, Liberale G, Hendlisz A, Sclafani F
Year : 2020
Journal : Cancer Treat Rev
Volume : 82
Pages : 101930
Imaging and clinical correlates with regorafenib in metastatic colorectal cancer.
Authors : Khan K, Cascinu S, Cunningham D, Kim SY, Oki E, Seery T, Shen L, Siena S, Tournigand C, Turhal NS, Hendlisz A
Year : 2020
Journal : Cancer Treat Rev
Volume : 86
Pages : 102020
Adjuvant chemotherapy in biliary tract cancer patients: A systematic review and meta-analysis of randomized controlled trials.
Authors : Caparica R, Bruzzone M, Hachem GE, Ceppi M, Lambertini M, Glasberg J, de Azambuja E, Van Laethem JL, Hendlisz A
Year : 2020
Journal : Crit Rev Oncol Hematol
Volume : 149
Pages : 102940